Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
Clinical trial NCT05193565 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05193565
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2026-07-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.